DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Coyle JT, Tsai G.
The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia.
Psychopharmacology 2004; 174 (1): 32-38
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.